RSI-MRI — a new entrant into the prostate cancer imaging field

According to an article published recently in Prostate Cancer and Prostatic Diseases, a “better” form of MRI may be able to improve the accuracy of prostate imaging over current techniques. … READ MORE …

Next prostate cancer CureTalk on January 20

The next CureTalk program on prostate cancer is scheduled for January 20, 2015, at 5:00 p.m. Eastern time in the USA. The featured speaker is Dr. James Mohler of the Roswell Park Cancer Center in Buffalo, New York. To register for this program, … READ MORE …

Potential new imaging agent in diagnosis, monitoring of prostate cancer

About 19 months ago we reported that a company called Progenics Pharmaceuticals had acquired all rights to a small, radiolabeled molecule known as [99mTc]MIP-1404, and that an international, multi-center Phase II trial was  investigating the clinical activity of [99mTc]MIP-1404 as a prostate cancer imaging agent. … READ MORE …

7-T MRIs in the diagnosis and work-up of localized prostate cancer

References to 1.5-T, 3-T, and 7-T MRI machines are based on the size and power of the magnets used in the creation of MRI images by the machines. The T stands for “tesla”. It is a measure of magnetic flux density, and one tesla (1 T) is equal to one weber per square metre (1 Wb/m2). … READ MORE …

Potential new imaging test for metastatic prostate cancer

According to a newly published study in the journal Cancer Research, a collaborative research team at the Massey Cancer Center of Virgina Commonwealth University and at Johns Hopkins has developed a new, systemically administered, non-invasive, molecular-genetic technique to image bone metastases resulting from prostate cancer. … READ MORE …

Current and future imaging techniques and recurrent prostate cancer

An article just reproduced on the Medscape Oncology web site provides a very readable review of what the authors describe as, “A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer”. … READ MORE …

Newer radio-tracer shows potential in imaging of recurrent prostate cancer

Data have been emerging for a while to suggest that a new imaging agent known as anti-3-[18F]FACBC (when used in PET/CT scans may be better than [11C]choline in the identification of recurrent (or primary) cancers on PET/CT scans or than older agents like [111In]capromab pendetide (Prostascint) when used in SPECT/CT scans. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,214 other followers